Timothy B Lowinger

Design and discovery of small molecules targeting raf-1 kinase.

B. Riedl, Jacques Dumas, J. Dumas, 2002, Current pharmaceutical design.

Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design.

P. Trail, T. Lowinger, Timothy B Lowinger, 2018, Pharmacology & therapeutics.

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituent.

Xiao-Gao Liu, Barbara Hibner, Joel Renick, 2004, Bioorganic & medicinal chemistry letters.